Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
1.470
+0.040 (2.80%)
At close: Apr 18, 2024, 4:00 PM
1.460
-0.010 (-0.68%)
After-hours: Apr 18, 2024, 6:49 PM EDT
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CATX stock have an average target of 1.53, with a low estimate of 1.40 and a high estimate of 1.70. The average target predicts an increase of 4.08% from the current stock price of 1.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CATX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $1.2 → $1.7 | Strong Buy | Maintains | $1.2 → $1.7 | +15.65% | Apr 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $1.2 → $1.5 | Buy | Reiterates | $1.2 → $1.5 | +2.04% | Apr 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $1.2 | Buy | Reiterates | $1.2 | -18.37% | Mar 19, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $1.2 | Strong Buy | Initiates | $1.2 | -18.37% | Jan 26, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $1.4 | Strong Buy | Initiates | $1.4 | -4.76% | Nov 15, 2023 |
Financial Forecast
Revenue This Year
510.00K
from 1.43M
Decreased by -64.44%
Revenue Next Year
4.42M
from 510.00K
Increased by 766.67%
EPS This Year
-0.09
from -0.17
EPS Next Year
-0.08
from -0.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.6M | 13.5M | 14.1M | 14.8M |
| Avg | 510,000 | 4.4M | 7.0M | 14.4M |
| Low | n/a | n/a | 200,900 | 13.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 9.8% | 2,537.5% | 219.5% | 112.9% |
| Avg | -64.4% | 766.7% | 57.6% | 106.8% |
| Low | - | - | -95.5% | 98.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.08 | -0.08 | -0.09 |
| Avg | -0.09 | -0.08 | -0.09 |
| Low | -0.10 | -0.08 | -0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.